HAP Trading’s Definium Therapeutics DFTX Stock Holding History

HAP Trading’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,537	Closed	-$196K	–	2629
2021 Q2	$235K	Buy	+4,537	New	+$238K	0.01%	943

Other funds holding DFTX

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DCI

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's DFTX Position: Q3 2021 in Review

HAP Trading sold out of Definium Therapeutics (DFTX) in Q3 2021, closing a stake of 4,537 shares — an estimated $196K sold.

HAP Trading first reported a position in DFTX in Q2 2021 and held it in 1 quarter. The position peaked at $235K in Q2 2021. 174 funds tracked by Wall St. Rank hold DFTX as of Q3 2021.

HAP Trading reported no remaining Definium Therapeutics position as of Q3 2021 after selling out during the quarter.
HAP Trading sold 4,537 Definium Therapeutics shares in Q3 2021, an estimated $196K.
HAP Trading first reported a position in Definium Therapeutics in Q2 2021 and held it in 1 quarter.
HAP Trading's Definium Therapeutics position peaked at $235K in Q2 2021.
174 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.